Nephrogenic systemic fibrosis

Olga Borys; Maria Majdan; Ewa Wielosz; Iwona Żychowska

eISSN: 2084-9834
ISSN: 0034-6233

Reumatologia/Rheumatology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2009
vol. 47

Send email

Copy url:

abstract:

Review paper

Nephrogenic systemic fibrosis

Olga Borys

,

Maria Majdan

,

Ewa Wielosz

,

Iwona Żychowska

Reumatologia 2009; 47, 1: 34-38

Online publish date: 2009/04/01

View full text Get citation

Development of new diagnostic and therapeutic technics makes possible to keep many patients alive. At the same time it carries risk of development of diseases which have not been observed in human pathology until now. Nephrogenic systemic fibrosis (NSF) is one of these diseases which is resembling systemic sclerodermia and characterized of skin and internal organs fibrosis. Without treatment this illness leads to the patients death. Patients who developed NSF were in advanced stages of chronic kidney disease. The relationship between exposure to gadolinium containing contrast agents and the appearance NSF symptoms was proved. Early diagnosis and prophylactic measures may prevent development of this disease. It is very important to inform physicians about this problem.

keywords:

nephrogenic systemic fibrosis, chronic kidney disease, gadolinium

EVENTS/KONFERENCJE

BOOKS/KSIĄŻKI

Nephrogenic systemic fibrosis

Olga Borys , Maria Majdan , Ewa Wielosz , Iwona Żychowska

nephrogenic systemic fibrosis, chronic kidney disease, gadolinium

Olga Borys

,

Maria Majdan

,

Ewa Wielosz

,

Iwona Żychowska